Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Hu Hai, explained in plain language.
This study tests a combination of two drugs, inavolisib and eribulin, in people with advanced triple-negative breast cancer that has a specific genetic change (PIK3CA mutation) and has not responded to at least one prior treatment. The goal is to see if the combination shrinks tu…
Phase: PHASE2 • Sponsor: Hu Hai • Aim: Disease control
Last updated May 18, 2026 12:04 UTC